1st Quarter - Report

BIOMET, INC. for BIOMET, INC.

Firm
Client
Income
—
Expenses
$130,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Section 510(k) of the Food, Drug & Cosmetic Act (Premarket Notification) - potential reforms

LobbyistCovered position, as disclosed
WILLIAM C KOLTER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.